Cargando…

The Potential Use of Radiomics with Pre-Radiation Therapy MR Imaging in Predicting Risk of Pseudoprogression in Glioblastoma Patients

Glioblastoma (GBM) is the most common adult glioma. Differentiating post-treatment effects such as pseudoprogression from true progression is paramount for treatment. Radiomics has been shown to predict overall survival and MGMT (methylguanine-DNA methyltransferase) promoter status in those with GBM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baine, Michael, Burr, Justin, Du, Qian, Zhang, Chi, Liang, Xiaoying, Krajewski, Luke, Zima, Laura, Rux, Gerard, Zheng, Dandan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321255/ https://www.ncbi.nlm.nih.gov/pubmed/34460616 http://dx.doi.org/10.3390/jimaging7020017

Ejemplares similares

Radiomics-Based Outcome Prediction for Pancreatic Cancer Following Stereotactic Body Radiotherapy
por: Parr, Elsa, et al.
Publicado: (2020)

Associations between Statin/Omega3 Usage and MRI-Based Radiomics Signatures in Prostate Cancer
por: Shi, Yu, et al.
Publicado: (2021)

Radiomic Analysis to Predict Histopathologically Confirmed Pseudoprogression in Glioblastoma Patients
por: McKenney, Anna Sophia, et al.
Publicado: (2022)

Glioblastoma with brainstem leptomeningeal pseudoprogression following radiation therapy
por: Kinger, Nikhar, et al.
Publicado: (2019)

Radiomics for pseudoprogression prediction in high grade gliomas: added value of MR contrast agent
por: Mammadov, Orkhan, et al.
Publicado: (2022)

Radiomics: The New Promise for Differentiating Progression, Recurrence, Pseudoprogression, and Radionecrosis in Glioma and Glioblastoma Multiforme
por: Alizadeh, Mohammadreza, et al.
Publicado: (2023)

Pseudoprogression as an adverse event of glioblastoma therapy
por: Balaña, Carmen, et al.
Publicado: (2017)

Using Quantitative Imaging for Personalized Medicine in Pancreatic Cancer: A Review of Radiomics and Deep Learning Applications
por: Preuss, Kiersten, et al.
Publicado: (2022)

Analysis of heterogeneity in T(2)-weighted MR images can differentiate pseudoprogression from progression in glioblastoma
por: Booth, Thomas C., et al.
Publicado: (2017)

A preliminary quantitative proteomic analysis of glioblastoma pseudoprogression
por: Zhang, Peng, et al.
Publicado: (2015)

Multicenter study demonstrates radiomic features derived from magnetic resonance perfusion images identify pseudoprogression in glioblastoma
por: Elshafeey, Nabil, et al.
Publicado: (2019)

Pseudoprogression prediction in high grade primary CNS tumors by use of radiomics
por: Ari, Asena Petek, et al.
Publicado: (2022)

High levels of cellular proliferation predict pseudoprogression in glioblastoma patients
por: POULEAU, HENRI-BENJAMIN, et al.
Publicado: (2011)

Pseudoprogression in Glioblastoma: Role of Metabolic and Functional MRI-Systematic Review
por: Sidibe, Ingrid, et al.
Publicado: (2022)

Multimodal MRI-Based Radiomic Nomogram for the Early Differentiation of Recurrence and Pseudoprogression of High-Grade Glioma
por: Jing, Hui, et al.
Publicado: (2022)

Radiomic feature stability across 4D respiratory phases and its impact on lung tumor prognosis prediction
por: Du, Qian, et al.
Publicado: (2019)

Early Pseudoprogression following Chemoradiotherapy in Glioblastoma Patients: The Value of RANO Evaluation
por: Linhares, Paulo, et al.
Publicado: (2013)

Prediction of Pseudoprogression versus Progression using Machine Learning Algorithm in Glioblastoma
por: Jang, Bum-Sup, et al.
Publicado: (2018)

Apatinib combined with temozolomide treatment for pseudoprogression in glioblastoma: A case report
por: Zhao, Mingming, et al.
Publicado: (2022)

Validation of multiparametric MRI based prediction model in identification of pseudoprogression in glioblastomas
por: de Godoy, Laiz Laura, et al.
Publicado: (2023)

Glioblastoma pseudoprogression and true progression reveal spatially variable transcriptional differences
por: Wang, Wesley, et al.
Publicado: (2023)

The Diagnosis and Treatment of Pseudoprogression, Radiation Necrosis and Brain Tumor Recurrence
por: Parvez, Kashif, et al.
Publicado: (2014)

Differentiation of pseudoprogression and real progression in glioblastoma using ADC parametric response maps
por: Reimer, Caroline, et al.
Publicado: (2017)

The predictive value of absolute lymphocyte counts on tumor progression and pseudoprogression in patients with glioblastoma
por: Xi, Jing, et al.
Publicado: (2021)

Advanced Imaging Techniques for Differentiating Pseudoprogression and Tumor Recurrence After Immunotherapy for Glioblastoma
por: Li, Yan, et al.
Publicado: (2021)

Recent Application of Advanced MR Imaging to Predict Pseudoprogression in High-grade Glioma Patients
por: YOO, Roh-EUL, et al.
Publicado: (2015)

Multiple oligodendroglioma with pseudoprogression
por: Matsuyama, Junko
Publicado: (2012)

Pseudoprogression of brain tumors
por: Thust, Stefanie C., et al.
Publicado: (2018)

Pseudoprogression and Immunotherapy Phenomena
por: Waxman, Elizabeth S., et al.
Publicado: (2020)

FET PET Radiomics for Differentiating Pseudoprogression from Early Tumor Progression in Glioma Patients Post-Chemoradiation
por: Lohmann, Philipp, et al.
Publicado: (2020)

Assessing the added value of apparent diffusion coefficient, cerebral blood volume, and radiomic magnetic resonance features for differentiation of pseudoprogression versus true tumor progression in patients with glioblastoma
por: Leone, Riccardo, et al.
Publicado: (2023)

Reevaluating the imaging definition of tumor progression: perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survival
por: Hu, Leland S., et al.
Publicado: (2012)

Stratification of pseudoprogression and true progression of glioblastoma multiform based on longitudinal diffusion tensor imaging without segmentation
por: Qian, Xiaohua, et al.
Publicado: (2016)

Pseudoprogression in low-grade glioma
por: Slater, Jason M., et al.
Publicado: (2019)

Magnetic resonance spectroscopy outperforms perfusion in distinguishing between pseudoprogression and disease progression in patients with glioblastoma
por: El-Abtah, Mohamed E, et al.
Publicado: (2022)

Effects of interobserver and interdisciplinary segmentation variabilities on CT-based radiomics for pancreatic cancer
por: Wong, Jeffrey, et al.
Publicado: (2021)

Differentiation of Pseudoprogression from True Progressionin Glioblastoma Patients after Standard Treatment: A Machine Learning Strategy Combinedwith Radiomics Features from T(1)-weighted Contrast-enhanced Imaging
por: Sun, Ying-Zhi, et al.
Publicado: (2021)

Three‐dimensional echo planar spectroscopic imaging for differentiation of true progression from pseudoprogression in patients with glioblastoma
por: Verma, Gaurav, et al.
Publicado: (2018)

Radiation Necrosis, Pseudoprogression, Pseudoresponse, and Tumor Recurrence: Imaging Challenges for the Evaluation of Treated Gliomas
por: Zikou, Anastasia, et al.
Publicado: (2018)

Brain metastases with poor vascular function are susceptible to pseudoprogression after stereotactic radiation surgery
por: Digernes, Ingrid, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qdmfd9fpvh50b8ltkiffd4mnt3